Overweight and obesity are characterized by profound changes in adipose tissue mass. These changes reflect, in part, significant differences in the number and size of adipocytes that comprise adipose tissue. In the last four years, we have demonstrated that the transcription factor, cAMP Response Element Binding Protein (CREB) plays important roles in the development of new fat cells from preadipocytes via adipogenesis, and the survival of mature adipocytes by blocking apoptotic cell death. Additional preliminary data show that CREB regulates the expression of the pro-adipogenic signaling molecule, protein kinase B/Akt in 3T3-L1 preadipocytes and adipocytes. These data have lead us to hypothesize that CREB and specific Akt isoforms are necessary for adipogenesis, and stimulate this process by increasing the expression and/or activity of C/EBP alpha, beta, and PPARgamma2. To address this hypothesis we propose four Specific Aims. The first Specific Aim will determine whether CREB and each Akt are necessary for adipogenic conversion, and determine whether the time course for expression and/or activation of these factors is crucial in promoting adipocytes differentiation.
Specific Aim 2 will assess the impact of CREB and each Akt isoform on the expression and activity of the """"""""master adipogenic regulators"""""""", C/EBP alpha, C/EBP beta and PPARgamma2.
Aim 3 will evaluate the ability of CREB and each Akt isoform to induce adipogenesis in cells deficient in C/EBPs alpha, beta, or PPARgamma2, and whether these master regulators can drive adipocyte differentiation in cells lacking CREB or each Akt. Finally, Aim 4 will investigate whether activation of CREB initiates the same adipogenic program as conventional hormonal inducing agents, and identify genes regulated by CREB during adipogenic conversion using gene microarray technology. These studies comprise a comprehensive research program to determine the necessity of CREB and Akts 1, 2, and 3 for adipogenesis, and reveal underlying functional interactions between CREB, Akts, and the master adipogenic regulators, C/EBP alpha, beta, and PPARgamma2. Given the putative importance of CREB and Akt in adipogenesis, this research program is likely to have a significant impact on our understanding of obesity and related diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK053969-08
Application #
6927946
Study Section
Endocrinology Study Section (END)
Program Officer
Haft, Carol R
Project Start
1998-08-01
Project End
2007-04-30
Budget Start
2005-05-01
Budget End
2006-04-30
Support Year
8
Fiscal Year
2005
Total Cost
$273,070
Indirect Cost
Name
University of Colorado Denver
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Garat, Chrystelle V; Crossno Jr, Joseph T; Sullivan, Timothy M et al. (2013) Inhibition of phosphatidylinositol 3-kinase/Akt signaling attenuates hypoxia-induced pulmonary artery remodeling and suppresses CREB depletion in arterial smooth muscle cells. J Cardiovasc Pharmacol 62:539-48
McCurdy, Carrie E; Schenk, Simon; Holliday, Michael J et al. (2012) Attenuated Pik3r1 expression prevents insulin resistance and adipose tissue macrophage accumulation in diet-induced obese mice. Diabetes 61:2495-505
Garat, Chrystelle V; Crossno Jr, Joseph T; Sullivan, Timothy M et al. (2010) Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 alpha' catalytic subunit. J Cardiovasc Pharmacol 55:469-80
Schauer, Irene E; Knaub, Leslie A; Lloyd, Monique et al. (2010) CREB downregulation in vascular disease: a common response to cardiovascular risk. Arterioscler Thromb Vasc Biol 30:733-41
Fox, Keith E; Colton, Lillester A; Erickson, Paul F et al. (2008) Regulation of cyclin D1 and Wnt10b gene expression by cAMP-responsive element-binding protein during early adipogenesis involves differential promoter methylation. J Biol Chem 283:35096-105
Schroeder-Gloeckler, Jill M; Rahman, Shaikh Mizanoor; Janssen, Rachel C et al. (2007) CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. J Biol Chem 282:15717-29
Crossno Jr, Joseph T; Majka, Susan M; Grazia, Todd et al. (2006) Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 116:3220-8
Fox, Keith E; Fankell, Dana M; Erickson, Paul F et al. (2006) Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J Biol Chem 281:40341-53
Zhang, Jiang-Wen; Klemm, Dwight J; Vinson, Charles et al. (2004) Role of CREB in transcriptional regulation of CCAAT/enhancer-binding protein beta gene during adipogenesis. J Biol Chem 279:4471-8
Reusch, Jane E B; Klemm, Dwight J (2003) Cyclic AMP response element-binding protein in the vessel wall: good or bad? Circulation 108:1164-6

Showing the most recent 10 out of 16 publications